Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Quarta

Showing results (41-50 of 83) with videos related to

Pageof 9
Sort By:
Progress in Cardiovascular Diseases|January 24, 2026
The new life of myectomy in the era of myosin inhibitorsGiovanni Quarta, Roberta Cattaneo, Giacomo Bonacchi, et al.
British Journal of Haematology|April 23, 2013
Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian WEBTHAL projectAntonio Piga, Filomena Longo, Khaled M Musallam, et al.
JACC. Cardiovascular Imaging|November 19, 2011
Evolution and clinical importance of fibrosis in HCMGiovanni Quarta, Agata Grasso, Ferdinando Pasquale, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|February 13, 2013
Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonanceGiovanni Quarta, Syed I Husain, Andrew S Flett, et al.
European Journal of Internal Medicine|January 18, 2011
Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemiasAlberto Fragasso, Angela Ciancio, Clara Mannarella, et al.
Heart (British Cardiac Society)|July 16, 2011
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathyConstantinos O'Mahony, Pier D Lambiase, Giovanni Quarta, et al.
Plos One|August 14, 2020
Clinical academic research in the time of Corona: A simulation study in England and a call for actionAmitava Banerjee, Michail Katsoulis, Alvina G Lai, et al.
American Journal of Hypertension|January 31, 2009
Evaluation of systolic properties in hypertensive patients with different degrees of diastolic dysfunction and normal ejection fractionSebastiano Sciarretta, Francesco Paneni, Giuseppino M Ciavarella, et al.
European Heart Journal|November 20, 2012
Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and CanadaAnnika F M Haywood, Nancy D Merner, Kathy A Hodgkinson, et al.
American Journal of Medical Genetics. Part A|June 20, 2017
Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation)Maya Yardeni, Omri Weisman, Hanna Mandel, et al.
Pageof 9

Showing results (41-50 of 83) with videos related to

Sort By:
Pageof 9
Progress in Cardiovascular Diseases|January 24, 2026
The new life of myectomy in the era of myosin inhibitorsGiovanni Quarta, Roberta Cattaneo, Giacomo Bonacchi, et al.
British Journal of Haematology|April 23, 2013
Assessment and management of iron overload in β-thalassaemia major patients during the 21st century: a real-life experience from the Italian WEBTHAL projectAntonio Piga, Filomena Longo, Khaled M Musallam, et al.
JACC. Cardiovascular Imaging|November 19, 2011
Evolution and clinical importance of fibrosis in HCMGiovanni Quarta, Agata Grasso, Ferdinando Pasquale, et al.
Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|February 13, 2013
Arrhythmogenic right ventricular cardiomyopathy mimics: role of cardiovascular magnetic resonanceGiovanni Quarta, Syed I Husain, Andrew S Flett, et al.
European Journal of Internal Medicine|January 18, 2011
Myocardial iron overload assessed by magnetic resonance imaging (MRI)T2* in multi-transfused patients with thalassemia and acquired anemiasAlberto Fragasso, Angela Ciancio, Clara Mannarella, et al.
Heart (British Cardiac Society)|July 16, 2011
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathyConstantinos O'Mahony, Pier D Lambiase, Giovanni Quarta, et al.
Plos One|August 14, 2020
Clinical academic research in the time of Corona: A simulation study in England and a call for actionAmitava Banerjee, Michail Katsoulis, Alvina G Lai, et al.
American Journal of Hypertension|January 31, 2009
Evaluation of systolic properties in hypertensive patients with different degrees of diastolic dysfunction and normal ejection fractionSebastiano Sciarretta, Francesco Paneni, Giuseppino M Ciavarella, et al.
European Heart Journal|November 20, 2012
Recurrent missense mutations in TMEM43 (ARVD5) due to founder effects cause arrhythmogenic cardiomyopathies in the UK and CanadaAnnika F M Haywood, Nancy D Merner, Kathy A Hodgkinson, et al.
American Journal of Medical Genetics. Part A|June 20, 2017
Psychiatric and cognitive characteristics of individuals with Danon disease (LAMP2 gene mutation)Maya Yardeni, Omri Weisman, Hanna Mandel, et al.
Pageof 9